David J. Nutt, DM, FRCP, FRCPsych, FMedSci

David J. Nutt, DM, FRCP, FRCPsych, FMedSci, has contributed 28 articles to Psychiatrist.com between 1998 and 2011. His work focuses on topics including depression, anxiety, posttraumatic stress disorder, anxiolytics, and psychiatry. He has frequently collaborated with Yves Lecrubier, Jonathan R. T. Davidson, James C. Ballenger, Andre Tylee, and Andrea L. Malizia.

Depression (MDD) Anxiety Posttraumatic Stress Disorder Anxiolytics Psychiatry

Frequent co-authors

Yves Lecrubier Jonathan R. T. Davidson James C. Ballenger Andre Tylee Andrea L. Malizia Arieh Y. Shalev David S. Baldwin George I. Papakostas

Educational Activity

Highlights of the International Consensus Statement on Major Depressive Disorder

June 15, 2011

David J. Nutt

Article

International Consensus Statement on Major Depressive Disorder

March 31, 2010

George I. Papakostas, Alan J. Gelenberg, David J. Nutt, et al

Article

Rationale for, Barriers to, and Appropriate Medication for the Long-Term Treatment of Depression

March 31, 2010

David J. Nutt

Letter to the Editor

Effects of Bupropion Augmentation in Escitalopram-Resistant Patients With Major Depressive Disorder: An Open-Label, Naturalistic Study

July 21, 2009

David J. Nutt, Eduard Maron, Triin Eller, et al

Supplement Article

Relationship of Neurotransmitters to the Symptoms of Major Depressive Disorder

April 30, 2008

David J. Nutt

Article

Consensus Statement on the Benefit to the Community of ESEMeD (European Study of the Epidemiology of Mental Disorders) Survey Data on Depression and Anxiety

January 15, 2007

David J. Nutt, David Mechanic, Ronald C. Kessler, et al

Article

The Role of Dopamine and Norepinephrine in Depression and Antidepressant Treatment

June 15, 2006

David J. Nutt

Article

Consensus Statement and Research Needs: The Role of Dopamine and Norepinephrine in Depression and Antidepressant Treatment

June 15, 2006

Madhukar H. Trivedi, George I. Papakostas, David J. Nutt, et al

Article

Structural and Functional Brain Changes in Posttraumatic Stress Disorder

January 1, 2004

David J. Nutt, Andrea L. Malizia

Article

Consensus Statement Update on Posttraumatic Stress Disorder From the International Consensus Group on Depression and Anxiety

January 1, 2004

David J. Nutt, Charles B. Nemeroff, Jonathan R. T. Davidson, et al

Article

Introduction: Update on Posttraumatic Stress Disorder

January 1, 2004

David J. Nutt, Jonathan R. T. Davidson, Yves Lecrubier, et al

Article

Consensus Statement on Transcultural Issues in Depression and Anxiety From the International Consensus Group on Depression and Anxiety

November 1, 2001

David J. Nutt, Jonathan R. T. Davidson, Yutaka Ono, et al

1 2 3 »

David J. Nutt, DM, FRCP, FRCPsych, FMedSci

Frequent co-authors

Highlights of the International Consensus Statement on Major Depressive Disorder

International Consensus Statement on Major Depressive Disorder

Rationale for, Barriers to, and Appropriate Medication for the Long-Term Treatment of Depression

Effects of Bupropion Augmentation in Escitalopram-Resistant Patients With Major Depressive Disorder: An Open-Label, Naturalistic Study

Relationship of Neurotransmitters to the Symptoms of Major Depressive Disorder

Consensus Statement on the Benefit to the Community of ESEMeD (European Study of the Epidemiology of Mental Disorders) Survey Data on Depression and Anxiety

The Role of Dopamine and Norepinephrine in Depression and Antidepressant Treatment

Consensus Statement and Research Needs: The Role of Dopamine and Norepinephrine in Depression and Antidepressant Treatment

Structural and Functional Brain Changes in Posttraumatic Stress Disorder

Consensus Statement Update on Posttraumatic Stress Disorder From the International Consensus Group on Depression and Anxiety

Introduction: Update on Posttraumatic Stress Disorder

Consensus Statement on Transcultural Issues in Depression and Anxiety From the International Consensus Group on Depression and Anxiety

ELSEWHERE:

FOLLOW US:

David J. Nutt, DM, FRCP, FRCPsych, FMedSci

Frequent co-authors

Highlights of the International Consensus Statement on Major Depressive Disorder

International Consensus Statement on Major Depressive Disorder

Rationale for, Barriers to, and Appropriate Medication for the Long-Term Treatment of Depression

Effects of Bupropion Augmentation in Escitalopram-Resistant Patients With Major Depressive Disorder: An Open-Label, Naturalistic Study

Relationship of Neurotransmitters to the Symptoms of Major Depressive Disorder

Consensus Statement on the Benefit to the Community of ESEMeD (European Study of the Epidemiology of Mental Disorders) Survey Data on Depression and Anxiety

The Role of Dopamine and Norepinephrine in Depression and Antidepressant Treatment

Consensus Statement and Research Needs: The Role of Dopamine and Norepinephrine in Depression and Antidepressant Treatment

Structural and Functional Brain Changes in Posttraumatic Stress Disorder

Consensus Statement Update on Posttraumatic Stress Disorder From the International Consensus Group on Depression and Anxiety

Introduction: Update on Posttraumatic Stress Disorder

Consensus Statement on Transcultural Issues in Depression and Anxiety From the International Consensus Group on Depression and Anxiety

Live Webinar and Q&A With Dr Deligiannidis

Subscribe to readmore articles

Live Webinar
and Q&A With
Dr Deligiannidis

Subscribe to read
more articles